207 related articles for article (PubMed ID: 31177884)
1. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis.
Bostanci Durmus A; Dincer Cengiz S; Yılmaz H; Candar T; Gursoy AY; Sinem Caglar G
J Obstet Gynaecol; 2019 Oct; 39(7):991-995. PubMed ID: 31177884
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
[TBL] [Abstract][Full Text] [Related]
3. Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Cakirca G; Turgut FH
Iran J Kidney Dis; 2018 Oct; 12(5):299-304. PubMed ID: 30367022
[TBL] [Abstract][Full Text] [Related]
4. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
6. Postpartum human breast milk levels of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9)/NGAL complex in normal and pregnancies complicated with insulin-dependent gestational diabetes mellitus. A prospective pilot case-control study.
Metallinou D; Lykeridou K; Karampas G; Liosis GT; Skevaki C; Rizou M; Papassotiriou I; Rizos D
J Obstet Gynaecol; 2020 May; 40(4):461-467. PubMed ID: 31353996
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
Dagher A; Curatolo A; Sachdev M; Stephens AJ; Mullins C; Landis JR; van Bokhoven A; El-Hayek A; Froehlich JW; Briscoe AC; Roy R; Yang J; Pontari MA; Zurakowski D; Lee RS; Moses MA;
BJU Int; 2017 Jul; 120(1):130-142. PubMed ID: 28263447
[TBL] [Abstract][Full Text] [Related]
9. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
Tsai HT; Su PH; Lee TH; Tee YT; Lin LY; Yang SF; Wang PH
Clin Chim Acta; 2011 Jun; 412(13-14):1252-6. PubMed ID: 21439274
[TBL] [Abstract][Full Text] [Related]
10. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Margeli A; Papassotiriou I
Eur J Endocrinol; 2008 Apr; 158(4):525-31. PubMed ID: 18362300
[TBL] [Abstract][Full Text] [Related]
12. Are there any new reliable markers to detect renal injury in obese children?
Bostan Gayret Ö; Taşdemir M; Erol M; Tekin Nacaroğlu H; Zengi O; Yiğit Ö
Ren Fail; 2018 Nov; 40(1):416-422. PubMed ID: 30035656
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Gelatinase Associated Lipocalin (NGAL) for Identification of Unstable Plaques in Patients with Asymptomatic Carotid Stenosis.
Eilenberg W; Stojkovic S; Kaider A; Piechota-Polanczyk A; Nanobachvili J; Domenig CM; Wojta J; Huk I; Demyanets S; Neumayer C
Eur J Vasc Endovasc Surg; 2019 Jun; 57(6):768-777. PubMed ID: 31164272
[TBL] [Abstract][Full Text] [Related]
14. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate: a longitudinal study.
Karampas G; Eleftheriades M; Panoulis K; Rizou M; Haliassos A; Hassiakos D; Vitoratos N; Rizos D
Prenat Diagn; 2014 Aug; 34(8):726-33. PubMed ID: 24550181
[TBL] [Abstract][Full Text] [Related]
18. Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children.
Korzeniecka-Kozerska A; Wasilewska A; Tenderenda E; Sulik A; Cybulski K
Dis Markers; 2013; 34(5):357-62. PubMed ID: 23478276
[TBL] [Abstract][Full Text] [Related]
19. Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis.
Barbe AM; Berbets AM; Davydenko IS; Koval HD; Yuzko VO; Yuzko OM
J Med Life; 2020; 13(3):314-320. PubMed ID: 33072202
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
